Characterization and in vitro hemocompatibility of bi-soft segment, polycaprolactone-based poly(ester urethane urea) membranes

被引:18
作者
Besteiro, Monica C. [1 ]
Guiomar, A. Jorge [1 ,2 ,3 ]
Goncalves, Carlos A. [4 ,5 ]
Bairos, Vasco A. [4 ,5 ]
de Pinho, Maria N. [6 ,7 ]
Gil, M. Helena [1 ]
机构
[1] Univ Coimbra, Fac Sci & Technol, Dept Chem Engn, Res Ctr Chem Proc Engn & Forest Prod, P-3030290 Coimbra, Portugal
[2] Univ Coimbra, Fac Sci & Technol, Dept Biochem, P-3001401 Coimbra, Portugal
[3] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal
[4] Univ Coimbra, Fac Med, Inst Histol & Embryol, P-3004504 Coimbra, Portugal
[5] Ctr Histophysiol Expt Pathol & Dev Biol, P-3004504 Coimbra, Portugal
[6] Inst Super Tecn, Dept Chem Engn, P-1049001 Lisbon, Portugal
[7] ICEMS, Inst Mat & Surfaces Sci & Engn, P-1049001 Lisbon, Portugal
关键词
bi-soft segment polyurethane; membrane; FTIR; surface; hemocompatibility; POLY(ETHER URETHANES); BLOOD COMPATIBILITY; SURFACE-PROPERTIES; CHAIN EXTENDERS; POLYMER BLENDS; FREE-ENERGY; POLYURETHANE; FTIR; SPECTROSCOPY; MORPHOLOGY;
D O I
10.1002/jbm.a.32594
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
In this study, surface, bulk, and hemocompatibility characteristics of crosslinked, hi-soft segment poly (ester urethane urea) membranes, prepared by extending a poly(propylene oxide)-based triisocyanate-terminated prepolymer (PU) with a polycaprolactone diol (PCL), were investigated. Variation of the ratio of PU to PCL diol content in the membrane formulation yielded alteration of surface energy, phase morphology both in the bulk and in the region near the surface, and it affected hemocompatibility. Nearly all membranes were nonhemolytic, with hemolysis degrees between 1 and 2.1% and, for short-time contact with blood (15 mm), all membranes showed in vitro thrombosis degrees between 27 and 42%. The membranes prepared with 5 and 25% of PCL diol showed almost no adherent platelets. These two membranes had a higher hard segment aggregation in the region near the surface and mixing between the two soft segments in the bulk, but showed contrasting surface energy characteristics. The results obtained in this work give evidence that surface energy and its polar and dispersive components did not correlate with any of the hemocompatibility aspects studied. In contrast, the phase morphology in the region near the surface was a major influence on membrane hemocompatibility. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 954-964, 2010
引用
收藏
页码:954 / 964
页数:11
相关论文
共 42 条
[1]
SURFACE MODIFICATION OF POLYMERS .5. BIOMATERIAL APPLICATIONS [J].
ALLMER, K ;
HILBORN, J ;
LARSSON, PH ;
HULT, A ;
RANBY, B .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 1990, 28 (01) :173-183
[2]
[Anonymous], BIOMATERIALS SCI INT
[3]
[Anonymous], 2002, 109934 ISO
[4]
[Anonymous], 2017, Standard Practice for Assessment of Hemolytic Properties of Materials
[5]
Structure and mechanical properties of thermoplastic polyurethane, based an hyperbranched polyesters [J].
Cao, Qi ;
Cai, Yuanli ;
Jing, Bo ;
Liu, Pengsheng .
JOURNAL OF APPLIED POLYMER SCIENCE, 2006, 102 (06) :5266-5273
[6]
BLOOD-MATERIALS INTERACTIONS - THE MINIMUM INTERFACIAL FREE-ENERGY AND THE OPTIMUM POLAR APOLAR RATIO HYPOTHESES [J].
COLEMAN, DL ;
GREGONIS, DE ;
ANDRADE, JD .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1982, 16 (04) :381-398
[7]
HYDROGEN-BONDING IN POLYMER BLENDS .1. FTIR STUDIES OF URETHANE ETHER BLENDS [J].
COLEMAN, MM ;
SKROVANEK, DJ ;
HU, JB ;
PAINTER, PC .
MACROMOLECULES, 1988, 21 (01) :59-65
[8]
FOURIER-TRANSFORM INFRARED STUDIES OF POLYMER BLENDS .2. POLY(EPSILON-CAPROLACTONE)-POLY(VINYL CHLORIDE) SYSTEM [J].
COLEMAN, MM ;
ZARIAN, J .
JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS, 1979, 17 (05) :837-850
[9]
XPS and SIMS characterisation of segmented polyether polyurethanes containing two different soft segments [J].
Deslandes, Y ;
Pleizier, G ;
Alexander, D ;
Santerre, P .
POLYMER, 1998, 39 (11) :2361-2366
[10]
Development of a new photocrosslinkable biodegradable bioadhesive [J].
Ferreira, P. ;
Coelho, J. F. J. ;
Gil, M. H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 352 (1-2) :172-181